Sci Rep 7(1):9100
Advertisement So, where does that leave wellness brands
Rather than a quick fix, researchers emphasize that GLP-1 drugs are powerful tools that work best alongside broader approaches to health
Friedman School of Nutrition Science and Policy at Tufts University, recently served as lead chair and author of a clinical advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published across four peer-reviewed journals and issued by four leading organizations in lifestyle medicine, obesity medicine, and nutritionthe American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)
In the context of active GLP-1 weight loss where the physiological challenge is ongoing visible tightening may require 36 months of sustained protocol adherence
Results vary from person to person, and ongoing lifestyle changes are important for lasting success